Does treatment of new-onset hypertension reduce risk of stroke in the elderly?


An 83-year-old woman with a known history of osteoporosis presents to your clinic for a yearly evaluation and renewal of her prescription for alendronate (Fosamax). She had been fairly healthy and lives independently, remaining active in the community with various volunteer activities. At a recent health fair, a nurse measured her BP and said it was 180/94… (More)


  • Presentations referencing similar topics